Rooney Mary R, Rawlings Andreea M, Pankow James S, Echouffo Tcheugui Justin B, Coresh Josef, Sharrett A Richey, Selvin Elizabeth
Welch Center for Prevention, Epidemiology, and Clinical Research, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Kaiser Permanente Center for Health Research, Portland, Oregon.
JAMA Intern Med. 2021 Apr 1;181(4):511-519. doi: 10.1001/jamainternmed.2020.8774.
The term prediabetes is used to identify individuals at increased risk for diabetes. However, the natural history of prediabetes in older age is not well characterized.
To compare different prediabetes definitions and characterize the risks of prediabetes and diabetes among older adults in a community-based setting.
DESIGN, SETTING, AND PARTICIPANTS: In this prospective cohort analysis of 3412 older adults without diabetes from the Atherosclerosis Risk in Communities Study (baseline, 2011-2013), participants were contacted semiannually through December 31, 2017, and attended a follow-up visit between January 1, 2016, and December 31, 2017 (median [range] follow-up, 5.0 [0.1-6.5] years).
Prediabetes defined by a glycated hemoglobin (HbA1c) level of 5.7% to 6.4%, impaired fasting glucose (IFG) level (FG level of 100-125 mg/dL), either, or both.
Incident total diabetes (physician diagnosis, glucose-lowering medication use, HbA1c level ≥6.5%, or FG level ≥126 mg/dL).
A total of 3412 participants without diabetes (mean [SD] age, 75.6 [5.2] years; 2040 [60%] female; and 572 [17%] Black) attended visit 5 (2011-2013, baseline). Of the 3412 participants at baseline, a total of 2497 participants attended the follow-up visit or died. During the 6.5-year follow-up period, there were 156 incident total diabetes cases (118 diagnosed) and 434 deaths. A total of 1490 participants (44%) had HbA1c levels of 5.7% to 6.4%, 1996 (59%) had IFG, 2482 (73%) met the HbA1c or IFG criteria, and 1004 (29%) met both the HbA1c and IFG criteria. Among participants with HbA1c levels of 5.7% to 6.4% at baseline, 97 (9%) progressed to diabetes, 148 (13%) regressed to normoglycemia (HbA1c, <5.7%), and 207 (19%) died. Of those with IFG at baseline, 112 (8%) progressed to diabetes, 647 (44%) regressed to normoglycemia (FG, <100 mg/dL), and 236 (16%) died. Of those with baseline HbA1c levels less than 5.7%, 239 (17%) progressed to HbA1c levels of 5.7% to 6.4% and 41 (3%) developed diabetes. Of those with baseline FG levels less than 100 mg/dL, 80 (8%) progressed to IFG (FG, 100-125 mg/dL) and 26 (3%) developed diabetes.
In this community-based cohort study of older adults, the prevalence of prediabetes was high; however, during the study period, regression to normoglycemia or death was more frequent than progression to diabetes. These findings suggest that prediabetes may not be a robust diagnostic entity in older age.
术语“糖尿病前期”用于识别糖尿病风险增加的个体。然而,老年人群中糖尿病前期的自然病程尚未得到充分描述。
比较不同的糖尿病前期定义,并描述社区环境中老年人糖尿病前期和糖尿病的风险。
设计、地点和参与者:在这项对社区动脉粥样硬化风险研究中3412名无糖尿病的老年人进行的前瞻性队列分析中(基线时间为2011 - 2013年),在2017年12月31日前每半年与参与者联系一次,他们在2016年1月1日至2017年12月31日期间参加了随访(中位[范围]随访时间为5.0[0.1 - 6.5]年)。
糖化血红蛋白(HbA1c)水平为5.7%至6.4%、空腹血糖受损(IFG)水平(血糖水平为100 - 125mg/dL),或两者兼有来定义的糖尿病前期。
新发的总体糖尿病(医生诊断、使用降糖药物、HbA1c水平≥6.5%或血糖水平≥126mg/dL)。
共有341名无糖尿病的参与者(平均[标准差]年龄为75.6[5.2]岁;2040名[60%]为女性;572名[17%]为黑人)参加了第5次随访(2011 - 2013年,基线)。在基线时的3412名参与者中,共有2497名参与者参加了随访或死亡。在6.5年的随访期内,有156例新发总体糖尿病病例(118例确诊)和434例死亡。共有1490名参与者(44%)的HbA1c水平为5.7%至6.4%,1996名(59%)有IFG,2482名(73%)符合HbA1c或IFG标准,1004名(29%)同时符合HbA1c和IFG标准。在基线时HbA1c水平为5.7%至6.4%的参与者中,97名(9%)进展为糖尿病,148名(13%)回归至正常血糖(HbA1c,<5.7%),207名(19%)死亡。在基线时有IFG的参与者中,112名(8%)进展为糖尿病,647名(44%)回归至正常血糖(血糖,<100mg/dL),236名(16%)死亡。在基线时HbA1c水平低于5.7%的参与者中,239名(17%)进展至HbA1c水平为5.7%至6.4%,41名(3%)患糖尿病。在基线时血糖水平低于100mg/dL的参与者中,80名(8%)进展为IFG(血糖,100 - 125mg/dL),26名(3%)患糖尿病。
在这项针对老年人的社区队列研究中,糖尿病前期的患病率很高;然而,在研究期间,回归至正常血糖或死亡比进展为糖尿病更常见。这些发现表明,糖尿病前期在老年人中可能不是一个可靠的诊断实体。